Form D · Other

DiaVacs, Inc.

La Jolla, CA · CIK 0001575240

Offering snapshot reported Mar 20, 2015 · SEC filing

Reported sold
$850K
Offering amount: $4M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 11, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 20, 2015Initial$849,999No comparison10SEC filing
May 10, 2013Initial$90No comparison2SEC filing
Apr 24, 2013Initial$53No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-236313
Amounts reflect the sale of Series B Preferred Stock of the issuer. Concurrently, the issuer also extended an offer to exchange shares of its Series A Preferred Stock held by participating investors for shares of Series A-1 Preferred Stock for no value.

Source: Form D, filed Mar 20, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Daniel Bradbury Director, Executive
Alexander Casdin Director
James Gavin Director
Haro Hartounian Director, Executive
Alan Lewis Director
Edwin Naylor Director
Vern Norviel Executive
Dietrich Stephan Director

Issuer details

Industry: Other (See others in industry)

Address:
2223 Avenida De La Playa Suite 108
La Jolla, CA, 92037